Use of alternative medicine by patients with cancer in a rural area of Switzerland

Swiss Med Wkly. 2003 Apr 19;133(15-16):233-40. doi: 10.4414/smw.2003.10160.

Abstract

Background: Many cancer patients use alternative therapies in addition to conventional treatment. In a survey among such patients, we assessed the prevalence of and the motivation for alternative therapy use in a rural area of Switzerland.

Methods: From 1st February to 30th November 2001, we interviewed 108 patients treated in the oncology outpatient clinic of the Langenthal District General Hospital, Switzerland, using a structured questionnaire. 77% of the patients were female. 49% of the patients (i.e., 64% of the female patients) suffered from breast cancer.

Results: 42 (39%) of all patients had used an alternative therapy in addition to conventional treatment at least once. Mistletoe preparations were by far the most popular with a prevalence of 74%. Homeopathy (24%) and cancer diets (12%) were used less often. 79% of the patients seeking help from alternative treatment informed their treating oncologist and/or medical practitioner accordingly. 57% of the doctors encouraged their patients to continue the alternative treatment, none discouraged the patient to do so. The main reasons for the use of alternative therapy were: the desire to feel more hopeful (83%); "to do as much as possible myself to cure the disease" (83%); and to harness mental energy (62%). Only 19% of the patients hoped to be cured of cancer by alternative therapy.

Conclusions: The motivation to seek help from alternative treatment is not based on a distrust of conventional care. Maintaining hope and taking an active role in self-care are the main stimuli for using alternative medicine.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Aged
  • Attitude to Health*
  • Complementary Therapies / statistics & numerical data*
  • Female
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Neoplasms / etiology
  • Neoplasms / psychology
  • Neoplasms / therapy*
  • Plant Preparations / administration & dosage
  • Plant Proteins*
  • Prevalence
  • Ribosome Inactivating Proteins, Type 2
  • Rural Population*
  • Switzerland / epidemiology
  • Toxins, Biological / administration & dosage
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Plant Preparations
  • Plant Proteins
  • Ribosome Inactivating Proteins, Type 2
  • Toxins, Biological
  • ribosome inactivating protein, Viscum